GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MeiraGTx Holdings PLC (FRA:328) » Definitions » Price-to-Funds-From-Operations

MeiraGTx Holdings (FRA:328) Price-to-Funds-From-Operations : (As of Apr. 10, 2025)


View and export this data going back to 2019. Start your Free Trial

What is MeiraGTx Holdings Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


MeiraGTx Holdings Business Description

Traded in Other Exchanges
Address
450 East 29th Street, 14th Floor, New York, NY, USA, 10016
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.